European multicenter study on propionyl-L-carnitine in intermittent claudication. – Cost Effective Supplements

European multicenter study on propionyl-L-carnitine in intermittent claudication.

Quick navigation

Link
Conclusion
Supplements
Functions
Systems

Link to full study

http://www.ncbi.nlm.nih.gov/pubmed/10551714

Conclusion of this study

Claudicants with maximal walking distance < or = 250 m benefited from the use of propionyl-L-carnitine, with improvement in walking distance and quality of life. However, patients with mild functional impairment (i.e., walking distance > 250 m) showed no response to propionyl-L-carnitine.